about
Interactions of the cytoplasmic domains of human and simian retroviral transmembrane proteins with components of the clathrin adaptor complexes modulate intracellular and cell surface expression of envelope glycoproteinsAn envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptorTargeting of the human immunodeficiency virus type 1 envelope to the trans-Golgi network through binding to TIP47 is required for env incorporation into virions and infectivityA novel human T-leukemia virus type 1 cell-to-cell transmission assay permits definition of SU glycoprotein amino acids important for infectivityRole of a Putative gp41 Dimerization Domain in Human Immunodeficiency Virus Type 1 Membrane FusionStructural Characterization of HIV gp41 with the Membrane-proximal External RegionFunctional interaction between the cytoplasmic leucine-zipper domain of HIV-1 gp41 and p115-RhoGEFSynthesis, assembly, and processing of the Env ERVWE1/syncytin human endogenous retroviral envelope.Mutational analysis of the envelope protein of spleen necrosis virusMapping of receptor binding domains in the envelope protein of spleen necrosis virusReconstitution of the ancestral glycoprotein of human endogenous retrovirus k and modulation of its functional activity by truncation of the cytoplasmic domainRab11-FIP1C and Rab14 direct plasma membrane sorting and particle incorporation of the HIV-1 envelope glycoprotein complex.SIRE-1, a copia/Ty1-like retroelement from soybean, encodes a retroviral envelope-like protein.cDNA sequence and genomic characterization of intracisternal A-particle-related retroviral elements containing an envelope geneSubdomain folding and biological activity of the core structure from human immunodeficiency virus type 1 gp41: implications for viral membrane fusion.Antibody neutralization escape mediated by point mutations in the intracytoplasmic tail of human immunodeficiency virus type 1 gp41Type D retrovirus capsid assembly and release are active events requiring ATP.In vitro cell-free conversion of noninfectious Moloney retrovirus particles to an infectious form by the addition of the vesicular stomatitis virus surrogate envelope G proteinEvidence for cooperation between murine leukemia virus Env molecules in mixed oligomers.Steady-state plasma membrane expression of human cytomegalovirus gB is determined by the phosphorylation state of Ser900Characterization of the proline-rich region of murine leukemia virus envelope protein.Role of variable regions A and B in receptor binding domain of amphotropic murine leukemia virus envelope protein.A proline-rich motif downstream of the receptor binding domain modulates conformation and fusogenicity of murine retroviral envelopesActivation of a cell entry pathway common to type C mammalian retroviruses by soluble envelope fragmentsThe roles of tetraspanins in HIV-1 replication.Cell-dependent requirement of human immunodeficiency virus type 1 gp41 cytoplasmic tail for Env incorporation into virionsThe intracytoplasmic domain of the Env transmembrane protein is a locus for attenuation of simian immunodeficiency virus SIVmac in rhesus macaques.Coreceptor-dependent inhibition of the cell fusion activity of simian immunodeficiency virus Env proteins.Palmitoylation of the intracytoplasmic R peptide of the transmembrane envelope protein in Moloney murine leukemia virus.Palmitoylation of the Rous sarcoma virus transmembrane glycoprotein is required for protein stability and virus infectivity.Activation of membrane fusion by murine leukemia viruses is controlled in cis or in trans by interactions between the receptor-binding domain and a conserved disulfide loop of the carboxy terminus of the surface glycoprotein.Invertebrate retroviruses: ZAM a new candidate in D.melanogaster.Packaging cells for avian leukosis virus-based vectors with various host ranges.Opposing effects of a tyrosine-based sorting motif and a PDZ-binding motif regulate human T-lymphotropic virus type 1 envelope trafficking.Amino acid residues in the cytoplasmic domain of the Mason-Pfizer monkey virus glycoprotein critical for its incorporation into virions.Activity of the Mason-Pfizer monkey virus fusion protein is modulated by single amino acids in the cytoplasmic tail.Maturation-induced cloaking of neutralization epitopes on HIV-1 particles.Recurrent signature patterns in HIV-1 B clade envelope glycoproteins associated with either early or chronic infectionsTruncation of the cytoplasmic domain induces exposure of conserved regions in the ectodomain of human immunodeficiency virus type 1 envelope protein.Rational site-directed mutations of the LLP-1 and LLP-2 lentivirus lytic peptide domains in the intracytoplasmic tail of human immunodeficiency virus type 1 gp41 indicate common functions in cell-cell fusion but distinct roles in virion envelope inc
P2860
Q24517016-F78C5AF4-37B6-490A-BAA1-D80E5B78D663Q24524784-853BC935-E122-4967-98F6-478011BAB063Q24675430-FAD4B28A-6347-4628-A2AD-5C04DBCB5BE1Q27480768-8A8AD134-0F88-4307-B73E-C094EC7CB606Q27657871-065F0B35-E581-4A4D-B64E-29D23D21F924Q27662117-A1854537-B370-46D3-AE4A-D09143568BF1Q28137707-649F6417-3ED0-40FA-99AD-715DC99C9B82Q28244876-1DE50057-4E22-4116-BBBE-506355FFD022Q28284998-0EA2E05D-5171-4621-B8B9-8E74080E5E3BQ28302477-ADC7AE5F-5452-44CA-9303-5482475B1DEAQ28749689-B8CCE4AC-2D1A-4D1E-BDC1-5D96A4A4B36BQ31115300-D1786D0B-564B-451D-82C4-FEE783D1C78EQ32061666-D9ABF860-6C49-4640-9F95-DC74DC7BD493Q33407488-B17579B9-A84A-4BE4-97AE-C65DA9FE0CDDQ33648376-71644069-B973-4EC6-BABB-D7D7583D24BBQ33781344-B39E314F-4627-4F81-9EDE-6C6BC4FE3F2FQ33783128-5A57AFFA-CB52-46E7-A68B-73B41DBCE6F2Q33783325-810C1E67-134D-4F10-8A69-3C55CF566FBFQ33783521-2A8C6807-4F8B-4596-9EE9-63FC1E0675CCQ33783566-EBBF6AE8-BB74-4A08-8B37-C8ED551F196EQ33784874-56FC903F-AA3C-498F-9A6A-E8C7E0D2A1ECQ33785388-6C022119-4192-4FAC-B405-D9DE6D26476BQ33786094-BC939640-834B-435C-86F6-19A84F0D8463Q33794864-DAB07962-8B3D-4B5C-8225-BC6028808835Q33796306-3EBD8B77-92EE-4D6A-ABA7-F7EDB53AA1C3Q33805110-EAA17738-A72A-42DE-84EF-610BE5BF336BQ33806370-D381B2B7-D5CA-44AF-9BC1-8ED1986FD1AAQ33807244-413F4888-6E2E-4A1D-9A26-CEA6649F8B57Q33822435-7CA1AEDD-DC2D-4210-AD6A-93C6BA3F1705Q33849870-33E046CF-1E5F-4323-8AA6-ABD4145AA79CQ33851195-C1D65D3D-251A-46D5-AC06-C99A06B12450Q33887929-919BA926-0E8D-4D24-8A3E-BED9782F58D2Q33937664-4F747CA9-8279-4DDC-9E95-59A6452D9876Q33966652-155F4414-0108-45DE-BB7F-D97B7655B22EQ33987373-B7F4E0A6-7019-4F3D-879B-F27C9E3DB074Q33987377-E6A3FF5D-069B-406D-B5C6-BE5334435E96Q34023008-3AA58502-A018-4562-9899-3C101C993A2EQ34042642-A92D1024-859F-4EA9-A3FC-F58C68CD2D09Q34332519-12C45A96-E2C4-4AC1-8739-FB47A4E05252Q34741962-06A2FB44-D428-49A4-A95C-AA4037B02F8B
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Retrovirus envelope glycoproteins.
@en
Retrovirus envelope glycoproteins.
@nl
type
label
Retrovirus envelope glycoproteins.
@en
Retrovirus envelope glycoproteins.
@nl
prefLabel
Retrovirus envelope glycoproteins.
@en
Retrovirus envelope glycoproteins.
@nl
P1476
Retrovirus envelope glycoproteins.
@en
P2093
P304
P577
1990-01-01T00:00:00Z